Presentation is loading. Please wait.

Presentation is loading. Please wait.

The Early Phase (0-I-II) Clinical Drug Research Unit of Maastricht University Medical Center (MUMC) prof dr L. Van Bortel Drug Research Unit Maastricht.

Similar presentations


Presentation on theme: "The Early Phase (0-I-II) Clinical Drug Research Unit of Maastricht University Medical Center (MUMC) prof dr L. Van Bortel Drug Research Unit Maastricht."— Presentation transcript:

1 The Early Phase (0-I-II) Clinical Drug Research Unit of Maastricht University Medical Center (MUMC) prof dr L. Van Bortel Drug Research Unit Maastricht

2 Mission Statement To contribute to the development of new drugs by conducting early phase clinical trials (phase 0-I-II) in compliance with (inter)national legislation and quality standards

3 essential part in chain of drug development preclinical → early phase → phase 3&4 by filling the gap in the drug research chain facilitates translational research Position in MUMC-holding/valorisation chain

4 Close collaboration with Drug Research Unit Ghent (DRUG): 1 CEO for 2 units ↑ possibilities of conducting larger trials or trials with difficult recruitment DRUM can take advantage of the elaborated quality management system and training at DRUG Joint PR for internal and external sponsors Cross-fertilisation of know-how/methods … Strategic alliance

5 sponsors Pharmaceutical industry (+ nutriceuticals) Non for profit organisations MUMC Other University departments

6 What can DRUM offer sponsors State of the art conduct of early phase clinical studies High quality Large expertise Short timelines High flexibility Fair cost

7 What can DRUM offer sponsors State of the art conduct of early phase clinical studies High quality Large expertise Short timelines High flexibility Fair cost

8 Quality quality control – first party (internal) audits scheduled on main procedures ad hoc for (near) errors –training in SOP (all SOP’s revised within 2 yrs) –close feedback on the spot / approval system quality assurance – 1 GCP-ICH third party audit/yr –ISO 9001:2008 → 1 ISO audit/yr (within 1 year?)

9 What can DRUM offer sponsors State of the art conduct of early phase clinical studies High quality Large expertise Short timelines High flexibility Fair cost

10 Large expertise takes advantage of experts in 2 knowledge centers: MUMC - U(Z)Gent → many therapeutic areas → high tec investigations experience in early phase clinical drug research –principal investigator: 24 years –investigator: 4 years

11 What can DRUM offer sponsors State of the art conduct of early phase clinical studies High quality Large expertise Short timelines High flexibility Fair cost

12 Timelines (cfr DRUG) EC: Ethics Committee Number of working days Median 2005 Median 2006 Median 2007 Median 2008 Median 2009 From submission EC to final answer EC 14, From submission EC to first dosing From last monitoring visit to release of study data to monitor 13331

13 What can DRUM offer sponsors State of the art conduct of early phase clinical studies High quality Large expertise Short timelines High flexibility Fair cost

14 High flexibility Dose adjustments Pharmacy with GMPz Pharmacell bv with full GMP Additional safety measures Puts pressure on working hours/social environment of staff, particularly in the early years

15 What can DRUM offer the MUMC Service center for early phase drug investigations Take advantage of knowledge center (experts in MUMC) Facilitates education (training) in Medicine/ Health Sciences/clinical pharmacologist

16 staff Principal investigator - investigator - quality coordinator - managing coordinator - clinical research coordinator - trial nurse - office manager investigator/principal investigator experienced in early phase studies All are well-trained training at DRUG Highly motivated Bank personnel: trial nurses / co-investigators

17 facilities 16 beds for clinical research and overnight stay 2 sample handling laboratories (temperature controlled) 1 drug storage room (temperature controlled / alarm) 1 freezer (-18°C) + 1 (-70°C) temperature controlled / alarm) 2 refrigerators (temperature controlled / alarm) offices, archive, meeting room, reception, kitchen, storage room

18 facilities 16 beds for clinical research and overnight stay 2 sample handling laboratories (temperature controlled) 1 drug storage room (temperature controlled / alarm) 1 freezer (-18°C) + 1 (-70°C) temperature controlled / alarm) 2 refrigerators (temperature controlled / alarm) offices, archive, meeting room, reception, kitchen, storage room

19 facilities 16 beds for clinical research and overnight stay 2 sample handling laboratories (temperature controlled) 1 drug storage room (temperature controlled / alarm) 1 freezer (-18°C) + 1 (-70°C) temperature controlled / alarm) 2 refrigerators (temperature controlled / alarm) offices, archive, meeting room, reception, kitchen, storage room

20 Ready to start!

21 Summary Centre of Excellence (qualified staff / approval / external audits / ISO 9001:2008) short timelines, high flexibility takes advantage of university knowledge centre

22 YES, we can!


Download ppt "The Early Phase (0-I-II) Clinical Drug Research Unit of Maastricht University Medical Center (MUMC) prof dr L. Van Bortel Drug Research Unit Maastricht."

Similar presentations


Ads by Google